These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


512 related items for PubMed ID: 20386115

  • 1. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
    Watts BV, Groft A.
    J ECT; 2010 Sep; 26(3):213-7. PubMed ID: 20386115
    [Abstract] [Full Text] [Related]

  • 2. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder.
    Watts BV.
    J ECT; 2007 Jun; 23(2):93-5. PubMed ID: 17548978
    [Abstract] [Full Text] [Related]

  • 3. EFFICACY AND LONG-TERM CLINICAL OUTCOME OF COMORBID POSTTRAUMATIC STRESS DISORDER AND MAJOR DEPRESSIVE DISORDER AFTER ELECTROCONVULSIVE THERAPY.
    Ahmadi N, Moss L, Simon E, Nemeroff CB, Atre-Vaidya N.
    Depress Anxiety; 2016 Jul; 33(7):640-7. PubMed ID: 26555786
    [Abstract] [Full Text] [Related]

  • 4. The dexamethasone suppression test and ECT outcome: a six-month follow-up.
    Coryell W, Zimmerman M.
    Biol Psychiatry; 1983 Jan; 18(1):21-7. PubMed ID: 6830923
    [Abstract] [Full Text] [Related]

  • 5. Treatment of comorbid posttraumatic stress disorder and major depressive disorder: a pilot study.
    Nixon RD, Nearmy DM.
    J Trauma Stress; 2011 Aug; 24(4):451-5. PubMed ID: 21755543
    [Abstract] [Full Text] [Related]

  • 6. Changes in serial dexamethasone suppression tests among unipolar depressive receiving electroconvulsive treatment.
    Albala AA, Greden JF, Tarika J, Carroll BJ.
    Biol Psychiatry; 1981 Jun; 16(6):551-60. PubMed ID: 7260217
    [Abstract] [Full Text] [Related]

  • 7. Dexamethasone suppression test in borderline personality disorder--effects of posttraumatic stress disorder.
    Lange W, Wulff H, Berea C, Beblo T, Saavedra AS, Mensebach C, Wingenfeld K, Driessen M.
    Psychoneuroendocrinology; 2005 Oct; 30(9):919-23. PubMed ID: 15896918
    [Abstract] [Full Text] [Related]

  • 8. Differences in the response to the combined DEX-CRH test between PTSD patients with and without co-morbid depressive disorder.
    de Kloet C, Vermetten E, Lentjes E, Geuze E, van Pelt J, Manuel R, Heijnen C, Westenberg H.
    Psychoneuroendocrinology; 2008 Apr; 33(3):313-20. PubMed ID: 18215470
    [Abstract] [Full Text] [Related]

  • 9. Clinical outcome of maintenance electroconvulsive therapy in comorbid Posttraumatic Stress Disorder and major depressive disorder.
    Ahmadi N, Moss L, Hauser P, Nemeroff C, Atre-Vaidya N.
    J Psychiatr Res; 2018 Oct; 105():132-136. PubMed ID: 30219562
    [Abstract] [Full Text] [Related]

  • 10. Specificity of posttraumatic stress disorder symptoms: an investigation of comorbidity between posttraumatic stress disorder symptoms and depression in treatment-seeking veterans.
    Gros DF, Simms LJ, Acierno R.
    J Nerv Ment Dis; 2010 Dec; 198(12):885-90. PubMed ID: 21135640
    [Abstract] [Full Text] [Related]

  • 11. The DST as a predictor of acute response to treatment with ECT, chlorimipramine, amitriptyline, and phenelzine.
    Modai I, Rinsky H, Cygielman G.
    J Clin Psychiatry; 1986 Mar; 47(3):139-40. PubMed ID: 3949722
    [Abstract] [Full Text] [Related]

  • 12. Post-dexamethasone cortisol as a predictor for the efficacy of electroconvulsive therapy in depressed inpatients.
    Vukadin M, Birkenhäger TK, Wierdsma AI, Groenland TH, van den Broek WW.
    J Psychiatr Res; 2011 Sep; 45(9):1165-9. PubMed ID: 21481419
    [Abstract] [Full Text] [Related]

  • 13. Electroconvulsive therapy for depression with comorbid borderline personality disorder or post-traumatic stress disorder: A matched retrospective cohort study.
    Kaster TS, Goldbloom DS, Daskalakis ZJ, Mulsant BH, Blumberger DM.
    Brain Stimul; 2018 Sep; 11(1):204-212. PubMed ID: 29111076
    [Abstract] [Full Text] [Related]

  • 14. Predicting efficacy of electroconvulsive therapy in major depressive disorder.
    Tsuchiyama K, Nagayama H, Yamada K, Isogawa K, Katsuragi S, Kiyota A.
    Psychiatry Clin Neurosci; 2005 Oct; 59(5):546-50. PubMed ID: 16194256
    [Abstract] [Full Text] [Related]

  • 15. Predictors of response to electroconvulsive therapy obtained using the three-factor structure of the Montgomery and Asberg Depression Rating Scale for treatment-resistant depressed patients.
    Okazaki M, Tominaga K, Higuchi H, Utagawa I, Nakamura E, Noguchi M, Itaya M, Hashimoto C, Yamaguchi N.
    J ECT; 2010 Jun; 26(2):87-90. PubMed ID: 19710622
    [Abstract] [Full Text] [Related]

  • 16. Enhanced cortisol suppression in response to dexamethasone administration in traumatized veterans with and without posttraumatic stress disorder.
    de Kloet CS, Vermetten E, Heijnen CJ, Geuze E, Lentjes EG, Westenberg HG.
    Psychoneuroendocrinology; 2007 Apr; 32(3):215-26. PubMed ID: 17296270
    [Abstract] [Full Text] [Related]

  • 17. [Acute and chronic effects of electroconvulsive therapy on neuroactive steroids in patients with major depressive disorder].
    Ozsoy S, Eşel E, Hacimusalar Y, Candan Z, Kula M, Turan T.
    Turk Psikiyatri Derg; 2008 Apr; 19(4):341-8. PubMed ID: 19110975
    [Abstract] [Full Text] [Related]

  • 18. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
    Geretsegger C, Nickel M, Judendorfer B, Rochowanski E, Novak E, Aichhorn W.
    J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
    [Abstract] [Full Text] [Related]

  • 19. The influence of comorbid MDD on outcome after residential treatment for veterans with PTSD and a history of TBI.
    Walter KH, Barnes SM, Chard KM.
    J Trauma Stress; 2012 Aug; 25(4):426-32. PubMed ID: 22821663
    [Abstract] [Full Text] [Related]

  • 20. Serial dexamethasone suppression tests in initial suppressors and nonsuppressors treated with electroconvulsive therapy.
    Devanand DP, Decina P, Sackeim HA, Hopkins N, Novacenko H, Malitz S.
    Biol Psychiatry; 1987 Apr; 22(4):463-72. PubMed ID: 3567261
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.